Global and China Intravenous (IV) Therapy and Vein Access Market Size, Status and Forecast 2020-2026

Publisher Name :
Date: 24-Nov-2020
No. of pages: 96
Inquire Before Buying

Global Intravenous (IV) Therapy and Vein Access Scope and Market Size

Intravenous (IV) Therapy and Vein Access market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Intravenous (IV) Therapy and Vein Access market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

Market segment by Type, the product can be split into

- Infusion pumps

- Implantable Ports

- Intravenous Catheters

- Hypodermic Needles

- Other

Market segment by Application, split into

- Hospital

- Clinics

- Other

Based on regional and country-level analysis, the Intravenous (IV) Therapy and Vein Access market has been segmented as follows:

- North America

- - United States

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- - Nordic

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Australia

- - Rest of Asia-Pacific

- Latin America

- - Mexico

- - Brazil

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of Middle East & Africa

In the competitive analysis section of the report, leading as well as prominent players of the global Intravenous (IV) Therapy and Vein Access market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.

The key players covered in this study

- B. Braun

- Baxter International

- Becton Dickinson

- C. R. Bard

- Fresenius Kabi

- Hospira(ICU Medical)

- Medtronic

- Smiths Group

- Teleflex

Global and China Intravenous (IV) Therapy and Vein Access Market Size, Status and Forecast 2020-2026

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Intravenous (IV) Therapy and Vein Access Market Size Growth Rate by Type: 2020 VS 2026
1.2.2 Infusion pumps
1.2.3 Implantable Ports
1.2.4 Intravenous Catheters
1.2.5 Hypodermic Needles
1.2.6 Other
1.3 Market by Application
1.3.1 Global Intravenous (IV) Therapy and Vein Access Market Share by Application: 2020 VS 2026
1.3.2 Hospital
1.3.3 Clinics
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Intravenous (IV) Therapy and Vein Access Market Perspective (2015-2026)
2.2 Global Intravenous (IV) Therapy and Vein Access Growth Trends by Regions
2.2.1 Intravenous (IV) Therapy and Vein Access Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Intravenous (IV) Therapy and Vein Access Historic Market Share by Regions (2015-2020)
2.2.3 Intravenous (IV) Therapy and Vein Access Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Intravenous (IV) Therapy and Vein Access Players by Market Size
3.1.1 Global Top Intravenous (IV) Therapy and Vein Access Players by Revenue (2015-2020)
3.1.2 Global Intravenous (IV) Therapy and Vein Access Revenue Market Share by Players (2015-2020)
3.2 Global Intravenous (IV) Therapy and Vein Access Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Intravenous (IV) Therapy and Vein Access Revenue
3.4 Global Intravenous (IV) Therapy and Vein Access Market Concentration Ratio
3.4.1 Global Intravenous (IV) Therapy and Vein Access Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Intravenous (IV) Therapy and Vein Access Revenue in 2019
3.5 Key Players Intravenous (IV) Therapy and Vein Access Area Served
3.6 Key Players Intravenous (IV) Therapy and Vein Access Product Solution and Service
3.7 Date of Enter into Intravenous (IV) Therapy and Vein Access Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Intravenous (IV) Therapy and Vein Access Breakdown Data by Type (2015-2026)
4.1 Global Intravenous (IV) Therapy and Vein Access Historic Market Size by Type (2015-2020)
4.2 Global Intravenous (IV) Therapy and Vein Access Forecasted Market Size by Type (2021-2026)
5 Intravenous (IV) Therapy and Vein Access Breakdown Data by Application (2015-2026)
5.1 Global Intravenous (IV) Therapy and Vein Access Historic Market Size by Application (2015-2020)
5.2 Global Intravenous (IV) Therapy and Vein Access Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Intravenous (IV) Therapy and Vein Access Market Size (2015-2026)
6.2 North America Intravenous (IV) Therapy and Vein Access Market Size by Type (2015-2020)
6.3 North America Intravenous (IV) Therapy and Vein Access Market Size by Application (2015-2020)
6.4 North America Intravenous (IV) Therapy and Vein Access Market Size by Country (2015-2020)
6.4.1 United States
6.4.2 Canada
7 Europe
7.1 Europe Intravenous (IV) Therapy and Vein Access Market Size (2015-2026)
7.2 Europe Intravenous (IV) Therapy and Vein Access Market Size by Type (2015-2020)
7.3 Europe Intravenous (IV) Therapy and Vein Access Market Size by Application (2015-2020)
7.4 Europe Intravenous (IV) Therapy and Vein Access Market Size by Country (2015-2020)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
7.4.6 Nordic
7.4.7 Rest of Europe
8 China
8.1 China Intravenous (IV) Therapy and Vein Access Market Size (2015-2026)
8.2 China Intravenous (IV) Therapy and Vein Access Market Size by Type (2015-2020)
8.3 China Intravenous (IV) Therapy and Vein Access Market Size by Application (2015-2020)
8.4 China Intravenous (IV) Therapy and Vein Access Market Size by Region (2015-2020)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 Southeast Asia
8.4.5 India
8.4.6 Australia
8.4.7 Rest of Asia-Pacific
9 Japan
9.1 Japan Intravenous (IV) Therapy and Vein Access Market Size (2015-2026)
9.2 Japan Intravenous (IV) Therapy and Vein Access Market Size by Type (2015-2020)
9.3 Japan Intravenous (IV) Therapy and Vein Access Market Size by Application (2015-2020)
9.4 Japan Intravenous (IV) Therapy and Vein Access Market Size by Country (2015-2020)
9.4.1 Mexico
9.4.2 Brazil
10 Southeast Asia
10.1 Southeast Asia Intravenous (IV) Therapy and Vein Access Market Size (2015-2026)
10.2 Southeast Asia Intravenous (IV) Therapy and Vein Access Market Size by Type (2015-2020)
10.3 Southeast Asia Intravenous (IV) Therapy and Vein Access Market Size by Application (2015-2020)
10.4 Southeast Asia Intravenous (IV) Therapy and Vein Access Market Size by Country (2015-2020)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
10.4.4 Rest of Middle East & Africa
11 Key Players Profiles
11.1 B. Braun
11.1.1 B. Braun Company Details
11.1.2 B. Braun Business Overview
11.1.3 B. Braun Intravenous (IV) Therapy and Vein Access Introduction
11.1.4 B. Braun Revenue in Intravenous (IV) Therapy and Vein Access Business (2015-2020))
11.1.5 B. Braun Recent Development
11.2 Baxter International
11.2.1 Baxter International Company Details
11.2.2 Baxter International Business Overview
11.2.3 Baxter International Intravenous (IV) Therapy and Vein Access Introduction
11.2.4 Baxter International Revenue in Intravenous (IV) Therapy and Vein Access Business (2015-2020)
11.2.5 Baxter International Recent Development
11.3 Becton Dickinson
11.3.1 Becton Dickinson Company Details
11.3.2 Becton Dickinson Business Overview
11.3.3 Becton Dickinson Intravenous (IV) Therapy and Vein Access Introduction
11.3.4 Becton Dickinson Revenue in Intravenous (IV) Therapy and Vein Access Business (2015-2020)
11.3.5 Becton Dickinson Recent Development
11.4 C. R. Bard
11.4.1 C. R. Bard Company Details
11.4.2 C. R. Bard Business Overview
11.4.3 C. R. Bard Intravenous (IV) Therapy and Vein Access Introduction
11.4.4 C. R. Bard Revenue in Intravenous (IV) Therapy and Vein Access Business (2015-2020)
11.4.5 C. R. Bard Recent Development
11.5 Fresenius Kabi
11.5.1 Fresenius Kabi Company Details
11.5.2 Fresenius Kabi Business Overview
11.5.3 Fresenius Kabi Intravenous (IV) Therapy and Vein Access Introduction
11.5.4 Fresenius Kabi Revenue in Intravenous (IV) Therapy and Vein Access Business (2015-2020)
11.5.5 Fresenius Kabi Recent Development
11.6 Hospira(ICU Medical)
11.6.1 Hospira(ICU Medical) Company Details
11.6.2 Hospira(ICU Medical) Business Overview
11.6.3 Hospira(ICU Medical) Intravenous (IV) Therapy and Vein Access Introduction
11.6.4 Hospira(ICU Medical) Revenue in Intravenous (IV) Therapy and Vein Access Business (2015-2020)
11.6.5 Hospira(ICU Medical) Recent Development
11.7 Medtronic
11.7.1 Medtronic Company Details
11.7.2 Medtronic Business Overview
11.7.3 Medtronic Intravenous (IV) Therapy and Vein Access Introduction
11.7.4 Medtronic Revenue in Intravenous (IV) Therapy and Vein Access Business (2015-2020)
11.7.5 Medtronic Recent Development
11.8 Smiths Group
11.8.1 Smiths Group Company Details
11.8.2 Smiths Group Business Overview
11.8.3 Smiths Group Intravenous (IV) Therapy and Vein Access Introduction
11.8.4 Smiths Group Revenue in Intravenous (IV) Therapy and Vein Access Business (2015-2020)
11.8.5 Smiths Group Recent Development
11.9 Teleflex
11.9.1 Teleflex Company Details
11.9.2 Teleflex Business Overview
11.9.3 Teleflex Intravenous (IV) Therapy and Vein Access Introduction
11.9.4 Teleflex Revenue in Intravenous (IV) Therapy and Vein Access Business (2015-2020)
11.9.5 Teleflex Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Intravenous (IV) Therapy and Vein Access Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 3. Key Players of Infusion pumps
Table 4. Key Players of Implantable Ports
Table 5. Key Players of Intravenous Catheters
Table 6. Key Players of Hypodermic Needles
Table 7. Key Players of Other
Table 8. Global Intravenous (IV) Therapy and Vein Access Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 9. Global Intravenous (IV) Therapy and Vein Access Market Size by Regions (US$ Million): 2020 VS 2026
Table 10. Global Intravenous (IV) Therapy and Vein Access Market Size by Regions (2015-2020) (US$ Million)
Table 11. Global Intravenous (IV) Therapy and Vein Access Market Share by Regions (2015-2020)
Table 12. Global Intravenous (IV) Therapy and Vein Access Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 13. Global Intravenous (IV) Therapy and Vein Access Market Share by Regions (2021-2026)
Table 14. Intravenous (IV) Therapy and Vein Access Market Market Trends
Table 15. Intravenous (IV) Therapy and Vein Access Market Drivers
Table 16. Intravenous (IV) Therapy and Vein Access Market Challenges
Table 17. Intravenous (IV) Therapy and Vein Access Market Restraints
Table 18. Global Intravenous (IV) Therapy and Vein Access Revenue by Players (2015-2020) (US$ Million)
Table 19. Global Intravenous (IV) Therapy and Vein Access Market Share by Players (2015-2020)
Table 20. Global Top Intravenous (IV) Therapy and Vein Access Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Intravenous (IV) Therapy and Vein Access as of 2019)
Table 21. Global Intravenous (IV) Therapy and Vein Access by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Intravenous (IV) Therapy and Vein Access Product Solution and Service
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Intravenous (IV) Therapy and Vein Access Market Size by Type (2015-2020) (US$ Million)
Table 26. Global Intravenous (IV) Therapy and Vein Access Market Size Share by Type (2015-2020)
Table 27. Global Intravenous (IV) Therapy and Vein Access Revenue Market Share by Type (2021-2026)
Table 28. Global Intravenous (IV) Therapy and Vein Access Market Size Share by Application (2015-2020)
Table 29. Global Intravenous (IV) Therapy and Vein Access Market Size by Application (2015-2020) (US$ Million)
Table 30. Global Intravenous (IV) Therapy and Vein Access Market Size Share by Application (2021-2026)
Table 31. North America Intravenous (IV) Therapy and Vein Access Market Size by Type (2015-2020) (US$ Million)
Table 32. North America Intravenous (IV) Therapy and Vein Access Market Share by Type (2015-2020)
Table 33. North America Intravenous (IV) Therapy and Vein Access Market Size by Application (2015-2020) (US$ Million)
Table 34. North America Intravenous (IV) Therapy and Vein Access Market Share by Application (2015-2020)
Table 35. North America Intravenous (IV) Therapy and Vein Access Market Size by Country (US$ Million) (2015-2020)
Table 36. North America Intravenous (IV) Therapy and Vein Access Market Share by Country (2015-2020)
Table 37. Europe Intravenous (IV) Therapy and Vein Access Market Size by Type (2015-2020) (US$ Million)
Table 38. Europe Intravenous (IV) Therapy and Vein Access Market Share by Type (2015-2020)
Table 39. Europe Intravenous (IV) Therapy and Vein Access Market Size by Application (2015-2020) (US$ Million)
Table 40. Europe Intravenous (IV) Therapy and Vein Access Market Share by Application (2015-2020)
Table 41. Europe Intravenous (IV) Therapy and Vein Access Market Size by Country (US$ Million) (2015-2020)
Table 42. Europe Intravenous (IV) Therapy and Vein Access Market Share by Country (2015-2020)
Table 43. China Intravenous (IV) Therapy and Vein Access Market Size by Type (2015-2020) (US$ Million)
Table 44. China Intravenous (IV) Therapy and Vein Access Market Share by Type (2015-2020)
Table 45. China Intravenous (IV) Therapy and Vein Access Market Size by Application (2015-2020) (US$ Million)
Table 46. China Intravenous (IV) Therapy and Vein Access Market Share by Application (2015-2020)
Table 47. China Intravenous (IV) Therapy and Vein Access Market Size by Region (US$ Million) (2015-2020)
Table 48. China Intravenous (IV) Therapy and Vein Access Market Share by Region (2015-2020)
Table 49. Japan Intravenous (IV) Therapy and Vein Access Market Size by Type (2015-2020) (US$ Million)
Table 50. Japan Intravenous (IV) Therapy and Vein Access Market Share by Type (2015-2020)
Table 51. Japan Intravenous (IV) Therapy and Vein Access Market Size by Application (2015-2020) (US$ Million)
Table 52. Japan Intravenous (IV) Therapy and Vein Access Market Share by Application (2015-2020)
Table 53. Japan Intravenous (IV) Therapy and Vein Access Market Size by Country (US$ Million) (2015-2020)
Table 54. Japan Intravenous (IV) Therapy and Vein Access Market Share by Country (2015-2020)
Table 55. Southeast Asia Intravenous (IV) Therapy and Vein Access Market Size by Type (2015-2020) (US$ Million)
Table 56. Southeast Asia Intravenous (IV) Therapy and Vein Access Market Share by Type (2015-2020)
Table 57. Southeast Asia Intravenous (IV) Therapy and Vein Access Market Size by Application (2015-2020) (US$ Million)
Table 58. Southeast Asia Intravenous (IV) Therapy and Vein Access Market Share by Application (2015-2020)
Table 59. Southeast Asia Intravenous (IV) Therapy and Vein Access Market Size by Country (US$ Million) (2015-2020)
Table 60. Southeast Asia Intravenous (IV) Therapy and Vein Access Market Share by Country (2015-2020)
Table 61. B. Braun Company Details
Table 62. B. Braun Business Overview
Table 63. B. Braun Product
Table 64. B. Braun Revenue in Intravenous (IV) Therapy and Vein Access Business (2015-2020) (US$ Million)
Table 65. B. Braun Recent Development
Table 66. Baxter International Company Details
Table 67. Baxter International Business Overview
Table 68. Baxter International Product
Table 69. Baxter International Revenue in Intravenous (IV) Therapy and Vein Access Business (2015-2020) (US$ Million)
Table 70. Baxter International Recent Development
Table 71. Becton Dickinson Company Details
Table 72. Becton Dickinson Business Overview
Table 73. Becton Dickinson Product
Table 74. Becton Dickinson Revenue in Intravenous (IV) Therapy and Vein Access Business (2015-2020) (US$ Million)
Table 75. Becton Dickinson Recent Development
Table 76. C. R. Bard Company Details
Table 77. C. R. Bard Business Overview
Table 78. C. R. Bard Product
Table 79. C. R. Bard Revenue in Intravenous (IV) Therapy and Vein Access Business (2015-2020) (US$ Million)
Table 80. C. R. Bard Recent Development
Table 81. Fresenius Kabi Company Details
Table 82. Fresenius Kabi Business Overview
Table 83. Fresenius Kabi Product
Table 84. Fresenius Kabi Revenue in Intravenous (IV) Therapy and Vein Access Business (2015-2020) (US$ Million)
Table 85. Fresenius Kabi Recent Development
Table 86. Hospira(ICU Medical) Company Details
Table 87. Hospira(ICU Medical) Business Overview
Table 88. Hospira(ICU Medical) Product
Table 89. Hospira(ICU Medical) Revenue in Intravenous (IV) Therapy and Vein Access Business (2015-2020) (US$ Million)
Table 90. Hospira(ICU Medical) Recent Development
Table 91. Medtronic Company Details
Table 92. Medtronic Business Overview
Table 93. Medtronic Product
Table 94. Medtronic Revenue in Intravenous (IV) Therapy and Vein Access Business (2015-2020) (US$ Million)
Table 95. Medtronic Recent Development
Table 96. Smiths Group Business Overview
Table 97. Smiths Group Product
Table 98. Smiths Group Company Details
Table 99. Smiths Group Revenue in Intravenous (IV) Therapy and Vein Access Business (2015-2020) (US$ Million)
Table 100. Smiths Group Recent Development
Table 101. Teleflex Company Details
Table 102. Teleflex Business Overview
Table 103. Teleflex Product
Table 104. Teleflex Revenue in Intravenous (IV) Therapy and Vein Access Business (2015-2020) (US$ Million)
Table 105. Teleflex Recent Development
Table 106. Research Programs/Design for This Report
Table 107. Key Data Information from Secondary Sources
Table 108. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Intravenous (IV) Therapy and Vein Access Market Share by Type: 2020 VS 2026
Figure 2. Infusion pumps Features
Figure 3. Implantable Ports Features
Figure 4. Intravenous Catheters Features
Figure 5. Hypodermic Needles Features
Figure 6. Other Features
Figure 7. Global Intravenous (IV) Therapy and Vein Access Market Share by Application: 2020 VS 2026
Figure 8. Hospital Case Studies
Figure 9. Clinics Case Studies
Figure 10. Other Case Studies
Figure 11. Intravenous (IV) Therapy and Vein Access Report Years Considered
Figure 12. Global Intravenous (IV) Therapy and Vein Access Market Size (US$ Million), YoY Growth 2015-2026
Figure 13. Global Intravenous (IV) Therapy and Vein Access Market Share by Regions: 2020 VS 2026
Figure 14. Global Intravenous (IV) Therapy and Vein Access Market Share by Regions (2021-2026)
Figure 15. Global Intravenous (IV) Therapy and Vein Access Market Share by Players in 2019
Figure 16. Global Top Intravenous (IV) Therapy and Vein Access Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Intravenous (IV) Therapy and Vein Access as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Intravenous (IV) Therapy and Vein Access Revenue in 2019
Figure 18. North America Intravenous (IV) Therapy and Vein Access Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 19. United States Intravenous (IV) Therapy and Vein Access Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 20. Canada Intravenous (IV) Therapy and Vein Access Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 21. Europe Intravenous (IV) Therapy and Vein Access Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 22. Germany Intravenous (IV) Therapy and Vein Access Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 23. France Intravenous (IV) Therapy and Vein Access Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 24. U.K. Intravenous (IV) Therapy and Vein Access Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 25. Italy Intravenous (IV) Therapy and Vein Access Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 26. Russia Intravenous (IV) Therapy and Vein Access Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 27. Nordic Intravenous (IV) Therapy and Vein Access Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 28. Rest of Europe Intravenous (IV) Therapy and Vein Access Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 29. Asia-Pacific Intravenous (IV) Therapy and Vein Access Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 30. China Intravenous (IV) Therapy and Vein Access Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 31. Japan Intravenous (IV) Therapy and Vein Access Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 32. South Korea Intravenous (IV) Therapy and Vein Access Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 33. Southeast Asia Intravenous (IV) Therapy and Vein Access Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 34. India Intravenous (IV) Therapy and Vein Access Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 35. Australia Intravenous (IV) Therapy and Vein Access Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 36. Rest of Asia-Pacific Intravenous (IV) Therapy and Vein Access Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 37. Latin America Intravenous (IV) Therapy and Vein Access Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 38. Mexico Intravenous (IV) Therapy and Vein Access Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 39. Brazil Intravenous (IV) Therapy and Vein Access Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 40. Middle East & Africa Intravenous (IV) Therapy and Vein Access Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 41. Turkey Intravenous (IV) Therapy and Vein Access Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 42. Saudi Arabia Intravenous (IV) Therapy and Vein Access Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 43. UAE Intravenous (IV) Therapy and Vein Access Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 44. Rest of Middle East & Africa Intravenous (IV) Therapy and Vein Access Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 45. B. Braun Revenue Growth Rate in Intravenous (IV) Therapy and Vein Access Business (2015-2020)
Figure 46. Baxter International Revenue Growth Rate in Intravenous (IV) Therapy and Vein Access Business (2015-2020)
Figure 47. Becton Dickinson Revenue Growth Rate in Intravenous (IV) Therapy and Vein Access Business (2015-2020)
Figure 48. C. R. Bard Revenue Growth Rate in Intravenous (IV) Therapy and Vein Access Business (2015-2020)
Figure 49. Fresenius Kabi Revenue Growth Rate in Intravenous (IV) Therapy and Vein Access Business (2015-2020)
Figure 50. Hospira(ICU Medical) Revenue Growth Rate in Intravenous (IV) Therapy and Vein Access Business (2015-2020)
Figure 51. Medtronic Revenue Growth Rate in Intravenous (IV) Therapy and Vein Access Business (2015-2020)
Figure 52. Smiths Group Revenue Growth Rate in Intravenous (IV) Therapy and Vein Access Business (2015-2020)
Figure 53. Teleflex Revenue Growth Rate in Intravenous (IV) Therapy and Vein Access Business (2015-2020)
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed
  • Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029
    Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118
    The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......
  • Global Non-imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95
    The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90
    The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......
  • Global PCR Equipment Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77
    The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......
  • Global Disposable Sterile Syringes and Needles Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109
    The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......
  • Global Orthopaedic Power Tools Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......
  • Global Cerebrospinal Fluid Management Devices Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......
  • Global CAD & CAM Milling Burs Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79
    The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......
  • Global Artificial Teeth Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98
    The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs